+
Site Tour
MITRACLIP
MITRAL VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

 

MitraClip™ is the first minimally invasive TEER* therapy that delivers a life-changing treatment option for selected patients with Primary Mitral Regurgitation (PMR) or Secondary Mitral Regurgitation (SMR) who would otherwise go untreated.1,2 MitraClip™ is the standard of care in TMVr built on proven mitral valve therapy with over 20 years of experience, an extensive body of clinical evidence, and more than 200,000 patients treated worldwide.3

*TEER is also referred to TMVr (Transcatheter Mitral Valve repair)

TAILORED. OPTIMIZED. PROVEN.
MITRACLIP™ G4

MitraClip™ TEER system’s dedicated design for the mitral anatomy optimizes navigation for consistent clinical results. Its proven performance and tailored treatment options allow it to treat the broadest range of mitral anatomies.

Broad Range of Sizes for Tailored Treatment8,9


MitraClip™ G4 now offers four Clip sizes to help tailor repair based on patient mitral valve anatomy.

  • G4 NT is the original MitraClip™ NT/NTR Clip size.
  • G4 XT is the equivalent of XTR, with Clip arms that are 3mm longer than G4 NT and allow for easier grasping due to better reach.**


The G4 NTW and XTW clips have a 50% wider grasping area than the NT and XT clips respectively. They are designed to further reduce regurgitant volume of MR with the implantation of a single clip.**

Treat more patients with more options7,8

MITRACLIP™ SUCCESSFULLY TREATS A BROAD RANGE OF VALVE ANATOMIES IN REAL-WORLD USE8,9

 

NEARLY 1 IN 5 PATIENTS TREATED HAVE VALVE ANATOMIES CONSIDERED COMPLEX8

Valve anatomies include: presence of severely degenerative leaflets, wide flail gaps or widths, calcified landing zone, wide jet, primary jet outside of A2/P2, and more.8

Long arm clip use was associated with improved MR reduction for severe
baseline MR, smaller annular dimensions, larger prolapse gaps and complex
mitral valve anatomy in PMR.

Cardiac Surgeon with over 10 years of experience with MitraClip™*

CLIP SELECTION RECOMMENDATIONS BASED ON MITRAL VALVE ANATOMY7,8**

Valve anatomies include: presence of severely degenerative leaflets, wide flail gaps or widths, calcified landing zone, wide jet, primary jet outside of A2/P2, and more.8

CLIP SELECTION CONSIDERATIONS FAVORS G4 NTW FAVORS G4 NT FAVORS G4 XTW FAVORS G4 XT
Leaflet Length < 9mm    
Leaflet Length ≥ 9mm    
Broad Jet    
Smaller Valve      
Larger Valve  

MitraClip™ G4 clip selection recommendations are based on the clinical experience of physicians. The EXPAND G4 observational study evaluates adherence to clip size selection recommendations and their associated outcomes.

More options to confirm and optimize leaflet grasping with Controlled Gripper Actuation (CGA)1**

CGA provides the option to grasp leaflets simultaneously or independently, enabling the ability to confirm and optimize leaflet grasp.

Predictable procedure experience7**

The innovative clip delivery system is a highly manoeuvrable delivery catheter that is used to implant the MitraClip™ via a steerable guide catheter.
 

PRECISION AND CONTROL FROM DELIVERY SYSTEM SPECIFICALLY DESIGNED FOR THE MITRAL VALVE**

Increased procedural efficiency1,9

IN OUR INSTITUTE, WE HAVE NOW REDUCED DEVICE TIME TO ~20 MIN.

Echocardiographer with 6 years of MitraClip™ experience, commenting on MitraClip™ G4*

SIMPLIFIED PROCEDURAL STEPS1

  • 40% reduction in system preparation steps
  • Simplified system deployment with minimal number of steps

 

Connext
Live

REGISTER FOR OUR
VIRTUAL VENUE

Hear expert opinions first hand and collaborate on best practices.

Find out more

TV

Oops, an error occurred! Code: 20240519152133c87d8242
References

*The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may have to the treatment or effectiveness of the product or therapy in discussion. Opinions about the treatment discussed can and do vary and are specific to the individual’s experience and might not be representative of others.

**Tests performed by and data on file at Abbott.

  1. MitraClip™ G4 System Instructions for Use.
  2. Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after the transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64(2):182–192. doi.org/10.1016/j.jacc.2013.10.021.
  3. Data on file at Abbott.
  4. Heidenreich PA, Bozkurt B, Allen LA, et al. “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association. Joint Committee on Clinical Practice Guidelines.” J Am Coll Cardiol. 2022;28(5):E1–E167. doi.org/10.1016/j.cardfail.2022.02.010.
  5. Mirabel M, Lung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–1365. doi.org/10.1093/eurheartj/ehm001.
  6. Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail. 2005;7(7):1112–1117. doi.org/10.1016/j.ejheart.2005.01.016.
  7. Rottbauer WD. Contemporary Clinical Outcomes with MitraClip™ (NTR/XTR) System: Core-lab Echo Results from +1000 Patient the Global EXPAND Study. Data presented at PCR 2020.
  8. Maisano F. Clip Selection Strategy and Outcomes with MitraClip™ (NTR/XTR): Evidence-Based Recommendations from the Global EXPAND Study. Data presented at PCR 2020.
  9. Rodriguez E. Contemporary Outcomes with the MitraClip™ G4 System: Preliminary Results based on the EXPAND G4 Study. Data presented at TCT 2021.
  10. Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J.2022;43(7):561–632, doi.org/10.1093/eurheartj/ehab395.
  11. Yeo KK, Tan JWC, Muller DW, et al. Asian Pacific Society of Cardiology Consensus Recommendations on the Use of MitraClip for Mitral Regurgitation. Eur Cardiol. 2021;16:e25. doi.org/10.15420/ecr.2021.01.
  12. McDonagh TA, Metra M, Adamo M, et al., ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J.2012; 42(36):3599–3726, doi.org/10.1093/eurheartj/ehab368.

 

© Abbott 2023. All rights reserved. 9-EH-5-14377-01 07-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline